医学成像试剂市场规模、份额和增长分析：按类别、技术、应用和地区划分 - 行业预测，2024-2031 年

Medical Imaging Reagents Market Size, Share, Growth Analysis, By Class, By Technology, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年医学影像试剂市场规模预计为195.5亿美元，预测期内（2024-2031年）复合年增长率为9.20%，从2023年的213.5亿美元增至2031年的431.7亿美元。美元。

医学成像试剂市场是医疗保健产业的重要组成部分，为诊断和研究提供重要工具。这些试剂可提高 MRI、CT、超音波和核子医学等成像技术中组织和器官的可见度。主要市场驱动因素包括慢性病发病率上升、人口老化以及早期准确诊断的需求。向分子成像的转变提供了功能和代谢见解以及解剖细节，正在推动对特定分子进行个人化治疗的先进试剂的需求。 PET/CT 和 SPECT/CT 等混合影像系统推动了与多个平台相容的多功能试剂的需求。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

GE Healthcare（USA）
Siemens Healthineers（Germany）
Thermo Fisher Scientific（USA）
Bayer AG（Germany）
Bracco Imaging SpA（Italy）
Lantheus Medical Imaging（USA）
Mallinckrodt Pharmaceuticals（USA）
Koninklijke Philips NV（Netherlands）
Fujifilm Holdings Corporation（Japan）
PerkinElmer（USA）
Hologic, Inc.（USA）
EliTechGroup（France）
Curium Pharma（France）
NanoScan Imaging（USA）
Eisai Co., Ltd.（Japan）
JB Chemicals & Pharmaceuticals Ltd.（India）
Nordion Inc.（Canada）
Jubilant Life Sciences Ltd.（India）
Astellas Pharma, Inc.（Japan）
Cyclopharm Ltd.（Australia）
Cardinal Health, Inc.（USA）
Life Molecular Imaging（Germany）
AdvaCare Pharma（USA）
The Medical House PLC（UK）
Lumiphore, Inc.（USA）

简介目录

Product Code: SQMIG35A2744

Medical Imaging Reagents Market size was valued at USD 19.55 Billion in 2022 and is poised to grow from USD 21.35 Billion in 2023 to USD 43.17 Billion by 2031, at a CAGR of 9.20% during the forecast period (2024-2031).

The Medical Imaging Reagents Market is an essential component of the healthcare sector, providing critical tools for diagnostics and research. These reagents enhance tissue and organ visibility in imaging techniques like MRI, CT, ultrasound, and nuclear medicine. Key market drivers include rising chronic disease rates, an ageing population, and the need for early, accurate diagnoses. The shift towards molecular imaging, offering functional and metabolic insights along with anatomical details, has increased the demand for advanced reagents that target specific molecules for personalized treatment. Ongoing R&D efforts focus on developing safer, more efficient reagents, while hybrid imaging systems like PET/CT and SPECT/CT fuel the need for versatile reagents compatible with multiple platforms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segmental Analysis

The global medical imaging reagents market is segmented on the basis of class, technology, application and region. By class, the market is segmented into Contrast Reagents, Optical Reagents, and Nuclear Reagents. By technology, the market is segmented into Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots. By application, the market is segmented into Diagnostics, Drug Discovery & Development, Educational Research. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Medical Imaging Reagents Market

The rising incidence of chronic diseases like cancer, cardiovascular disorders, and neurological conditions has significantly boosted the need for advanced medical imaging procedures. This surge in demand underscores the critical role of medical imaging reagents, which enhance the precision and efficacy of diagnostic imaging techniques. As these reagents improve the clarity and detail of imaging results, they become indispensable in accurately diagnosing and monitoring these complex diseases, thereby driving their widespread use in the medical field. This trend highlights the vital importance of innovation and accessibility in medical imaging technologies to meet the growing healthcare challenges.

Restraints in the Medical Imaging Reagents Market

Medical imaging reagents, particularly those utilized in advanced imaging modalities such as PET and MRI, often come with high costs. The expenses associated with these reagents, along with the sophisticated equipment and related healthcare services, pose a substantial financial challenge for both healthcare facilities and patients. This economic barrier can hinder the market's expansion, especially in regions with lower income levels, where the financial strain is more pronounced. Consequently, the high costs can restrict access to these advanced imaging techniques, potentially impacting the quality of healthcare and diagnostic capabilities in economically disadvantaged areas.

Market Trends of the Medical Imaging Reagents Market

The demand for molecular imaging reagents, particularly PET and SPECT radiopharmaceuticals, has been on the rise due to their critical role in visualizing and quantifying biological processes at the molecular and cellular levels. This capability is essential for early disease detection, precise treatment planning, and ongoing monitoring. The trend is fueled by advancements in radiopharmaceutical development, which have led to the creation of more targeted and specific imaging agents, enhancing their effectiveness and precision in medical diagnostics and research. These innovations are revolutionizing the field, making molecular imaging an indispensable tool in modern healthcare.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Key Success Factors
Market Attractiveness Index
Degree of Competition
Top Investment Pockets
Ecosystem Mapping

Medical Imaging Reagents Market by Class

Market Overview
Contrast Reagents
Optical Reagents
Nuclear Reagents

Medical Imaging Reagents Market by Technology

Market Overview
Nanoparticles
Fluorescent Dyes & Probes
Radiopharmaceuticals
Fluorescent Proteins
Quantum Dots

Medical Imaging Reagents Market by Application

Market Overview
Dignostic
Drug discovery & Technology
Educational Research

Medical Imaging Reagents Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Medical Imaging (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EliTechGroup (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoScan Imaging (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eisai Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J.B. Chemicals & Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Life Sciences Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyclopharm Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Life Molecular Imaging (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AdvaCare Pharma (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Medical House PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumiphore, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments